alpha biomed glp 1 Introducing Tirzepatide! We are now offering weight loss injections starting at $250. Tirzepatide, also known as Wegovy and Manjouri, contains the active ingredient in the well known Ozempic. Call or book now GLP-1 Advanced Metabolic Extra Strength

Description

With tirzepatide, there is now one GIP/GLP-1 receptor dual agonist with a promising development that may find a prominent place in the treatment algorithm for the therapy of T2D and possibly also for obesity

Semaglutide GLP-1 has been shown to reduce visceral adipose tissue, or belly fat, in patients with obesity

Starting at the full 2.4 mg dose would produce severe nausea, vomiting, and other gastrointestinal distress in most individuals

Market Restraints Gastrointestinal Adverse Effects and Stringent Regulatory Requirements Restrain Market Expansion GLP-1 receptor agonists are associated with gastrointestinal side effects such as nausea, vomiting, diarrhea, and reduced appetite, particularly during treatment initiation and dose escalation